Skip to main content
Clinical Trials/NCT05942924
NCT05942924RecruitingNot Applicable

A Randomised Trial of Repetitive Versus Selective Tactile Stimulation for Preterm Infants At Birth: the NEU-STIM Trial

Leiden University Medical Center48 sites in 20 countries3,280 target enrollmentStarted: March 11, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
3,280
Locations
48
Primary Endpoint
SpO2>80

Study Overview

Brief Summary

The aim of this study is to determine the effect of repetitive tactile stimulation compared to selective stimulation on oxygenation of the infant at 5 minutes after birth. Infants born before 32 weeks of gestation will be included in this trial. This is a stepped-wedge cluster randomised controlled trial. The participating centre, rather than the individual infant, will be the unit of randomisation. This design is appropriate to test the effect of an intervention that encompasses a behavioral aspect - in this case the performance of tactile stimulation.

Detailed Description

Rationale: A randomised study demonstrated that preterm infants who received repetitive stimulation at birth (10 second episodes of stroking of the soles of the feet and/or back, followed by 10 seconds rest) showed an increase in respiratory effort. This may in turn improve clinical outcomes as improved breathing effort may reduce the need for invasive respiratory support. Tactile stimulation can be immediately and easily performed at birth at no extra cost. It therefore has great potential to be implemented in delivery rooms (DRs) worldwide.

Objective: To determine the effect of repetitive tactile stimulation compared to selective stimulation on oxygenation of the infant at 5 minutes after birth.

Study design: This is a stepped-wedge cluster randomised controlled trial. The participating centre, rather than the individual infant, will be the unit of randomisation. This design is appropriate to test the effect of an intervention that encompasses a behavioral aspect - in this case the performance of tactile stimulation.

Study population: Infants born before 32 weeks of gestation will be included in this trial.

Intervention: At the start of the study, each participating centre will perform selective tactile stimulation in accordance with international guidelines, as is their usual practice. Clinicians will gently rub the back, chest, extremities or soles of the feet if they consider the breathing of the infant to be insufficient or absent. In the second stage of the study, centres will be randomised to switch their stimulation approach to repetitive stimulation. Clinicians will then gently rub the back, chest, extremities or soles of the feet for 10 seconds. To avoid extinction of the stimulatory effect (reflex), every 10 second period of stimulation will be followed by 10 seconds of rest (no stimulation). Repetitive stimulation will be performed for the first 5 minutes of life, or longer if the breathing is still considered insufficient or absent.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Masking Description

Centres will be randomised for the fortnight at which they will switch their tactile stimulation practice from selective stimulation to repetitive stimulation. The analysing researcher will be blinded for the allocation of treatment switch.

Eligibility Criteria

Ages
— to 32 Weeks (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Infants born before 32 weeks of gestation can be included in this trial after parental consent.

Exclusion Criteria

  • Infants will be excluded if they are found to have a congenital abnormality or condition that has an adverse effect on breathing/ventilation or oxygenation, including: congenital diaphragmatic hernia, trachea-oesophageal fistula, cyanotic heart disease and surfactant protein deficiency. Many of the infants enrolled in the study will later be diagnosed with respiratory distress syndrome (RDS); this will not render them ineligible for inclusion.

Outcomes

Primary Outcomes

SpO2>80

Time Frame: At 5 minutes of life

Proportion of infants with pre-ductal SpO2 \>80%

Secondary Outcomes

  • Number of infants who received PPV <10min(Within 10 minutes after birth)
  • Number of infants who received CPAP <10min(Within 10 minutes after birth)
  • Heart rate(At 5 minutes after birth)
  • Death <10min(Within 10 minutes after birth)
  • Number of infants who were intubated <10min(Within 10 minutes after birth)
  • Number of infants who received chest compressions <10min(Within 10 minutes after birth)
  • Number of infants who were administered adrenaline <10min(Within 10 minutes after birth)
  • Number of infants who were administered volume expansion <10min(Within 10 minutes after birth)
  • Death(In the first week after birth)
  • Max FiO2(In the first 10 minutes after birth)
  • Number of infants who were supported by CPAP in first week(In the first week after birth)
  • Number of infants who received surfactant in first week(In the first week after birth)
  • Surfactant doses(In the first week after birth)
  • Number of infants who were mechanically ventilated(In the first week after birth)
  • Number of infants with abnormalities on the first cranial ultrasound(In first week after birth)
  • Cord clamping time(During resuscitation at birth)

Investigators

Sponsor
Leiden University Medical Center
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Janneke Dekker

Principal Investigator

Leiden University Medical Center

Study Sites (48)

Loading locations...

Similar Trials